60 Degrees Pharmaceuticals
SXTP
8 hedge funds and large institutions have $340K invested in 60 Degrees Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.
1,408% more capital invested
Capital invested by funds: $22.5K → $340K (+$318K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
18.11% more ownership
Funds ownership: 0.26% → 18.37% (+18%)
14% more funds holding
Funds holding: 7 → 8 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kathmere Capital Management
Wayne,
Pennsylvania
|
+$411K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$88.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.4K |
| 4 |
Barclays
London,
United Kingdom
|
+$4.2K |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$142 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$11.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.42K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$16 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Kathmere Capital Management
Wayne,
Pennsylvania
| $253K | +$411K | +144,683 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $55K | +$88.2K | +31,041 | +8,412% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $28.5K | +$37.4K | +13,183 | +424% |
|
|
4
Barclays
London,
United Kingdom
| $3.25K | +$4.2K | +1,478 | +391% |
|
|
NA
5
NewEdge Advisors
New Orleans,
Louisiana
| $88 | +$142 | +50 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $43 | – | – | – |
|
|
TPWA
7
Twin Peaks Wealth Advisors
Burlingame,
California
| $14 | +$23 | +8 | New |
|
8
Citigroup
New York
| $2 | +$3 | +1 | New |
|
|
9
Jane Street
New York
| – | -$11.2K | -5,513 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$3.42K | -1,685 | Closed |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$16 | -8 | Closed |
|
SXTP Hedge Fund Activity: Q1 2026 in Review
8 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q1 2026, worth a combined $340K — up 1,408% from $22.5K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SXTP positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Kathmere Capital Management, opening a new position worth an estimated $411K. The largest seller was Jane Street, exiting entirely with an estimated $11.2K sold.
- 8 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q1 2026, up from 7 in Q4 2025.
- Funds reported $340K of 60 Degrees Pharmaceuticals stock for Q1 2026, up 1,408% quarter-over-quarter.
- 4 funds opened new 60 Degrees Pharmaceuticals positions in Q1 2026 and 3 closed out, a net change of +1 holder.
- The largest 60 Degrees Pharmaceuticals buyer in Q1 2026 was Kathmere Capital Management, an estimated $411K added.
- The largest 60 Degrees Pharmaceuticals seller in Q1 2026 was Jane Street, an estimated $11.2K sold.
Based on aggregated 13F filings for Q1 2026.